139. Development of cefiderocol resistance in an Enterobacter hormaechei strain following prolonged antibiotic exposure

BACKGROUND: Cefiderocol (FDC) is a novel antimicrobial agent used for multi-drug resistant Gram-negative pathogens. To date, reports of mutations in β-lactamase and siderophore complex genes have been described and may contribute to FDC resistance. This case describes a New Dehli metallo-β-lactamase...

Descripción completa

Detalles Bibliográficos
Autores principales: Medernach, Rachel, Moore, William J, Nozick, Sophia, Alamri, Maha M, Kling, Kendall, Ison, Michael G, Chao, Qi, Bachta, Kelly E R, Rhodes, Nathaniel J, Ozer, Egon A, Hauser, Alan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751782/
http://dx.doi.org/10.1093/ofid/ofac492.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751782/
http://dx.doi.org/10.1093/ofid/ofac492.217

Ejemplares similares